INOVIO PHARMACEUTICALS, INC.: accounts_receivable
| Value | {"amount": 4003680, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2022-03-31) |
| Status | current |
| Entity | INOVIO PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:22:47.430238+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/0f66019b-5cfd-487a-a0fb-995b4dbc9c70
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001055726-22-000034 · Open the official SEC filing →Retrieved: 2026-08-19T10:22:47.430238+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001055726/accounts-receivable/2022-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/0f66019b-5cfd-487a-a0fb-995b4dbc9c70
History
- no predecessors — first report